Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Pfizer Limited, Sandwich, Kent, CT13 9NJ, United Kingdom
Neurontin 100 mg hard capsules.
| Pharmaceutical Form |
|---|
|
Capsule, hard. A two-piece, white opaque hard gelatin capsule, imprinted with ‘Neurontin 100 mg’ and ‘PD’ and containing a white to off-white powder. |
Each 100 mg hard capsule contains 100 mg of gabapentin.
Excipients with known effect: Each 100 mg hard capsule contains 13 mg lactose (as monohydrate).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Gabapentin |
Gabapentin readily enters the brain and prevents seizures in a number of animal models of epilepsy. Gabapentin binds with high affinity to the α2δ (alpha-2-delta) subunit of voltage-gated calcium channels and it is proposed that binding to the α2δ subunit may be involved in gabapentin’s anti-seizure effects in animals. |
| List of Excipients |
|---|
|
Each hard capsule contains the following excipients: Lactose monohydrate Capsule shell: Gelatin The 100 mg hard capsules contain the colouring E171 (titanium dioxide). The printing ink used on all hard capsules contains shellac, E171 (titanium dioxide) and E132 (indigo carmine aluminium salt). |
PVC/PVDC/aluminium foil blister packs
Supplied in packs of 20, 30, 50, 60, 84, 90, 98, 100, 200, 500 or 1000 capsules.
Not all pack sizes may be marketed.
Pfizer Limited, Sandwich, Kent, CT13 9NJ, United Kingdom
PL 00057/0853
28th May 2007
| Drug | Countries | |
|---|---|---|
| NEURONTIN | Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Mexico, Netherlands, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
